3 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 2 | Terminated 2 |
Follow Metastatic Leiomyosarcoma: new trials by email Literature Review of Metastatic Leiomyosarcoma trials Research Report on Metastatic Leiomyosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas Itacitinib, Laboratory Biomarker Analysis - Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 27 | 2019-09-30 | 2024-05-08 |
| Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery Avelumab, Trabectedin - Metastatic Leiomyosarcoma, Metastatic Liposarcoma | Phase 1 / Phase 2 | Terminated | Fred Hutchinson Cancer Center | 35 | 2017-09-28 | 2022-04-29 |
| Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma Pazopanib, Pazopanib Hydrochloride, Sapanisertib - High Grade Sarcoma, Metastatic Leiomyosarcoma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 151 | 2015-11-30 | 2022-08-23 |
Leiomyosarcoma (3) · Histiocytoma, Malignant Fibrous (2) · Sarcoma, Synovial (2) · Chondrosarcoma (1) · Dermatofibrosarcoma (1) · Liposarcoma (1) · Liposarcoma, Myxoid (1) · Neurofibrosarcoma (1) · Sarcoma (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms, Muscle Tissue (3) · Histiocytoma (2) · Neoplasms, Adipose Tissue (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Fibrous Tissue (2) · Sarcoma (2) · Fibrosarcoma (1) · Liposarcoma (1) · Neoplasms, Nerve Tissue (1) · Nerve Sheath Neoplasms (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1)
INCB039110 (1) · Trabectedin (1) · avelumab (1) · baricitinib (1) · itacitinib (1) · pazopanib (1) · sapanisertib (1)
Fred Hutchinson Cancer Center (2) · National Cancer Institute (NCI) (1)
United States (3)
Lee Cranmer (1) · Seth Pollack (1) · William D Tap (1)
P30CA015704 (1), U10CA180821 (1)